We have just raised our price target and holding as well for ACRX
PT raised to $18
Holdings raised to 384,000 shares bought around an average of $9.70
Cohen Investment Group
Sentiment: Strong Buy
SNTS may adjust price of uceris once they get the Orphan Status for Microscopic Colitis
Price of uceris could easily double up.
Cohen Investment Target for SNTS 2014 is $54